By: Kristen Honey, Innovator in Residence, HHS Office of the Chief Technology Officer
The first-ever Lyme Innovation Roundtable at HHS brought together over 80 leaders to harness the power of collaboration, data-driven innovation, and emerging technologies for Lyme and tick-borne diseases.
By: Kristen Honey, Innovator in Residence, HHS Office of the Chief Technology Officer and Ed Simcox, HHS Chief Technology Officer
The Lyme Innovation initiative aims to accelerate innovation in the prevention, diagnosis and treatment of tick-borne diseases through the development of next-gen technologies, interdisciplinary collaborations, and data-driven innovations for tick-borne diseases.
As part of its innovation efforts around digital health, the Office of the Chief Technology Officer (CTO) announces a new pilot program modeled after The Opportunity Project (TOP) led by the Census Bureau at U.S. Department of Commerce.
The HHS Office of the Chief Technology Officer (CTO) and the the nonprofit Center for Open Data Enterprise (CODE) co-hosted a Roundtable on Data Sharing Policies, Data-Driven Solutions, and the Opioid Crisis in July.
Data has become one of the single most valuable currencies underpinning the revenue models of innumerable companies and promising efficiencies with the potential to yield improved results across every sector.
In coordination with the University of Washington, Northwest Kidney Centers, and the U.S. Department of Health and Human Services (HHS), the American Society of Nephrology (ASN) hosted a listening session for KidneyX on Wednesday, August 22.
To sign up for updates or to access your subscriber preferences, please enter your contact information below.
U.S. Department of Health & Human Services
200 Independence Avenue, S.W.
Washington, D.C. 20201
Toll Free Call Center: 1-877-696-6775
Divisions of HHS commonly use websites, blog entries, and social media posts to issue communications with regulated parties. While these communications may provide the public with helpful information they cannot, by themselves, impose binding new obligations on regulated entities.